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Previous work from these Laboratories has established the existence
of an abnormal hemoglobin in sickle cell trait and sickle cell anemia and
has provided the basis for a theory relating the presence of the abnormal
hemoglobin to the clinical pictures in sickle cell trait and sickle cell anemia.'
It was shown in this work that the electrophoretic picture in these condi-
tions is compatible with the usual genetic picture that both parents of an
individual suffering from sickle cell anemia have the sickle cell trait.2
There are in the literature, however, a number of reports in which one of
the parents of a sickle cell anemia victim possesses non-sickling erythro-
cytes. In some cases of this type the parent whose cells do not sickle has
been shown to have thalassemia minor (Cooley's trait), and hematologic
studies on the erythrocytes of the anemic individual have revealed the
presence of properties which are present in the erythrocytes both of sickle
cell disease and of thalassemia.3 4 In other cases the hemoglobin of the
parent having the non-sickling cells has a greater electrophoretic mobility
on the acid side of the isoelectric point than either normal hemoglobin or
sickle cell hemoglobin, and the hemoglobin of the anemic child contains
both this new hemoglobin and sickle cell hemoglobin.5
The present report deals with the identification of still another form of
human hemoglobin in five members of a family in which the genetic
picture is not typical of sickle cell anemia, although two of the members
have in the past been diagnosed as having sickle cell anemia. An earlier
study of this family disclosed that the two anemic children and the father,
who was not anemic, had sickling erythrocytes while the mother, two
sisters and two brothers of the anemic children had non-sickling erythro-
cytes and were not anemic.6 The father, one brother and one sister were
not available for the present study.
Experimental Methods.-(a) Sickling tests. The sodium dithionite,7
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sodium metabisulfite8 and moist seal9 methods were employed. The tests
were repeated on specimens which were negative for sickling.
(b) Electrophoretic studies. The methods described in previous reports
from these Laboratories were employed. 1"0 The carbonmonoxyhemo-
globins were studied.
(c) Solubility studies. The solubilities of the ferrohemoglobins prepared
from the erythrocytes of the members of this family were determined
in a series of concentrated phosphate buffers. The amorphous rather
than the crystalline state was examined for reasons which will be discussed
later. Similar studies were conducted on the ferrohemoglobins from
normal, sickle cell trait, and sickle cell anemia individuals for control pur-
poses. (1) Materials: Concentrated hemoglobin solutions were prepared
and were dialyzed against distilled water. A potassium phosphate buffer
having a total phosphate concentration of 2.8 molar and a pH of 6.8"1 was
prepared from reagent grade crystalline potassium dihydrogen phosphate
and dipotassium phosphate powder. (2) Experimental method: From
8.00 to 9.60 ml. of the concentrated phosphate buffer were delivered from
a buret into 10-ml. volumetric flasks, and 100 mg. of sodium dithionite,
Na2S204, was added to the buffer in each flask. The flasks were then
filled to the 10-ml. mark with aqueous hemoglobin solution or with the
hemoglobin solution and distilled water. The contents of the flasks were
mixed by manual shaking, and the precipitate was separated from the
solution by centrifugation. Experiments were discarded unless a visible
precipitate formed within a few seconds of the mixing. The absence of a pre-
cipitate indicates either undersaturation or supersaturation, the latter occur-
ring in some cases when the hemoglobin is present in but small excess.'2
Following the centrifugation, which caused the excess solid hemoglobin
to collect above the dense solution, the solution of hemoglobin in phosphate
buffer was removed. Its concentration was determined spectrophotometri-
cally immediately after saturation with carbon monoxide. The tempera-
ture of the solutions at the end of the centrifugations was 18° 4 20 C.
The ionic strength of each solution was calculated from the amounts of 2.8
molar phosphate buffer and sodium dithionite added. The amount of
hemoglobin present in each of the equilibrium mixtures was calculated from
the volume and concentration of the hemoglobin solutions added.
Results.-(a) Sickling tests. The erythrocytes of R. H., a male, and
B. H., a female, the two individuals who were previously reported as
being anemic, were positive for sickling, and virtually all of their red cells
sickled. The erythrocytes of their mother, M. H., a brother, G. H., and
a sister, H. H. D., did not sickle. Three different specimens of M. H.'s
blood were drawn and tested over a six-month period; at no time was
any sickling elicited in her cells in spite of numerous tests. These results
are in agreement with those reported in the previous study of this family.6
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(b) Electrophoretic studies. The electrophoretic behavior of the hemo-
globins of the two sickling individuals in this study, R. H. and B. H.,
appears to be the same as that previously found in cases of sickle cell
anemia. R. H.'s carbonmonoxyhemoglobin was analyzed both in phos-
phate buffer and in cacodylate buffer. The scanning diagram in phosphate
buffer of pH 6.90 and ionic strength 0.1 is identical to that previously pub-
lished, I and the mobility in this
buffer is 0.34 X 10-5 Cm.2 sec.-1
volt-'. The mobility determina-
tions of seven different specimens
of sickle cell anemia carbonmonoxy-
hemoglobin in this buffer averaged
0.33 X 10-5 Cm.2 sec.-' volt-. 13
In cacodylate-sodium chloride buf-
fer of pH 6.50 and ionic strength
0.1, the major component of the
carbonmonoxyhemoglobins from
both R. H. and B. H. has the
mobility of sickle cell carbonmon-
oxyhemoglobin. About 6% of R.
H.'s hemoglobin and 12% of B. H.'s
hemoglobin are present in this buf-
fer as a slow-moving component
having the approximate mobility of
normal carbonmonoxyhemoglobin.
These patterns in cacodylate buffer
are very similar to those found in
some cases of sickle cell anemia.5"l0
The scanning diagrams of the car-
bonmonoxyhemoglobins from M.
H., G. H., and H. H. D. in the ca-
codylate buffer are indistinguishable
from those obtained from individ-
uals having sickle cell trait.'0 Nor-











The solubilities in phosphate buffers at
180 C. of amorphous ferrohemoglobins from
three normal individuals, three individuals
having sickle cell trait and two individuals
having sickle cell anemia. One of the nor-
mal specimens and the sickle cell anemia
specimen having the lower solubility were
examined twice and are represented by two
series of points. Two curves are drawn
for the sickle cell anemia points because
the two specimens have slightly different
electrophoretic patterns (see discussion
section).
component which has the same mobility as sickle cell hemoglobin are
present. The percentages of the abnormal hemoglobin present are 42, 35,
and 49%, respectively, for M. H., H. H. D. and G. H.
(c) Solubility studies. The results are indicated by figures 1 and 2.
The points on the solubility curve for normal ferrohemoglobin represent
experiments on three different specimens of normal hemoglobin, one of
which was examined in two series of determinations. Specimens of hemo-
globin from three individuals having sickle cell trait and two having sickle
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cell anemia were examined. The anemia curve showing the higher solu-
bility represents a single series of determinations on a sickle cell anemia
hemoglobin specimen which shows on electrophoretic analysis approxi-
mately 16% of a slow component having the mobility of normal hemo-
globin. The other anemia curve represents two series of determinations
on a sickle cell anemia hemoglobin specimen having less than 5% of the
slow component. The solubilities of the hemoglobins of the sickling
members of the family being stud-
ied, R. H. and B. H., are between
those of sickle cell trait individuals
ILK RLK
.H. I and sickle cell anemia individuals.
, _ _ - The solubilities of the hemoglobins
X -_- s *\ from the non-sickling individuals,
s \ \ \ M. H. and G. H., are nearly the
a0.5 same as those of specimens of nor-a >t '\ +\ mal hemoglobin. H. H. D.'s hemo-
____ __xiglobin was not available in sufficient
0
\'\ \ quantity to run the solubility ex-
2
-. periments.
-0.5 .__ The solu bility behavior of a single
specimen of hemoglobin which con-
45 S 5 tains 6570 of normal hemoglobin
I
Sr and 35%0 of the new inherited ab-
FIGURE 2 normality reported by Itano and
The solubilities in phosphate buffers at Neel5 and of a single specimen of
180 C. of amorphous ferrohemoglobins from hemoglobin from an individual suf-
four members of the family under study. fering from thalassemia major
The dashed curve is the sickle cell trait
curve from Figure 1. M. H. and G. H. (Cooley's anemia) were investigated.
have two-component electrophoretic pat- The plot of the logarithm of the
terns similar to those found in sickle cell solubility against ionic strength for
trait. R. H. and B. H. have electropho- both these specimens fell within
retic patterns with one major component, 0.1 logarithm unit of the plot for
similar to those found in sickle cell anemia. normal hemoglobin.
(d) Summary of results. The hemoglobins from M. H., G. H., and
H. H. D. resemble the hemoglobins from individuals having sickle cell
trait in their electrophoretic behavior but differ in having a greater solu-
bility and in failing to cause sickling. Likewise, the hemoglobins from
R. H. and B. H. resemble hemoglobins from individuals having sickle cell
anemia in their electrophoretic behavior but differ in having a greater
solubility.
Nomenclature.-In order to facilitate the discussion in the present
paper and to avoid confusion in future works, it seems desirable at this
time to establish a system of symbols for identifying the various forms of
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adult human hemoglobin. Table 1 lists the characteristics of the four
forms of adult human hemoglobin which have been identified to date.
While the names normal hemoglobin and sickle cell hemoglobin adequately
describe the first two forms and will be used in this paper, names of equally
descriptive nature have not yet been proposed for the two newly recognized
forms. Therefore for purposes of identification and discussion normal
hemoglobin, sickle cell hemoglobin,1 the abnormal hemoglobin reported
by Itano and Neel,5 and the abnormal hemoglobin reported in the present
paper will be designated adult human hemoglobins a, b, c and d, respec-
tively, more briefly as hemoglobins a, b, c and d. Mixtures of these hemo-
TABLE I
CLASSIFICATION OF ADULT HUMAN HEMOGLOBINSe
NAME OF IDENTIFICA- CAUSES BLECTROPHORETIC
HEMOGLOBIN TION LETTER SICKLING MOBILITYb SOLUBILITYc
Normal a No Slow High
Sickle cell b Yes Intermediate Low
c No Fast High
d No Intermediate High
a The hemoglobin present in individuals having thalassemia major is not included
in this tabulation; some investigators are of the opinion that the abnormal properties
of this hemoglobin are due to the presence of fetal hemoglobin."9 10 The possibility
that the low-mobility component in the hemoglobins of R. H., B. H. and certain sickle
cell anemics may be fetal hemoglobin is being investigated.
b As carbonmonoxyhemoglobin in cacodylate-sodium chloride buffer of pH 6.50 and
ionic strength 0.1. In this buffer each of these carbonmonoxyhemoglobins migrates
as a positive ion.
c As amorphous ferrohemoglobin in concentrated phosphate buffers of pH 6.8 at 18°C.
globins which occur naturally may then be called hemoglobins ab, ad,
bc, etc. Hemoglobins c and d have not been found free of other hemo-
globins, and their behavior with respect to sickling and solubility are
inferred from the behavior of mixtures of c and d with a and b. The
solubilities of c and d are therefore not precisely known at this time, and
they have been grouped together with that of normal hemoglobin as
"high" with respect to that of sickle cell hemoglobin.
Discussion.-The results of the sickling tests conducted on the indi-
viduals who were available for this study are in complete agreement with
those found by the previous investigators of this family.6 These workers
noted in addition that the sickling was of the slow type in the sickling
individuals, an observation which implies that the constitution of their
erythrocytes is not identical with that of the fast sickling cells typically
found in sickle cell anemia.
The observation that the non-sickling erythrocytes of M. H., G. H. and
H. H. D. contain hemoglobin components14 which migrate like those
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found in sickle cell trait suggests two possible explanations. One explana-
tion, that the membrane and internal structure of these cells are abnormally
rigid and are able to withstand the tendency of the sickle cell hemoglobin
to aggregate, is a difficult one to test unambiguously. The other explana-
tion, that the abnormal component in these cells represents a hemoglobin
which, while migrating with the same mobility as sickle cell hemoglobin,
is actually a different molecular species, can be tested if an independent
criterion for differentiating hemoglobins can be employed. Solubility
differences exist among the hemoglobins of different species,'5 between
adult and fetal hemoglobins"6 and between normal and sickle cell hemo-
globins.'7' 18 The possibility that the abnormal hemoglobin in this familv
might have a characteristic solubility was therefore investigated.
Although in the majority of protein solubility studies crystalline protein
preparations are used, this procedure was undesirable in the present work
because the process of preparing crystals is likely to cause partial frac-
tionation of the components.'9 Other undesirable features of solubility
work on crystalline proteins are the length of time required for equilibra-
tion and the danger of supersaturation.'2 The low solubility of ferro-
hemoglobin in comparison with other compounds of hemoglobin'6 and the
large difference in the solubilities of normal and sickle cell ferrohemo-
globins suggested the use of this compound throughout the solubility
experiments. Another advantage of using this compound is the very small
dependence of its solubility on temperature. 16 The use of sodium dithionite
served a double purpose; any ferrihemoglobin which forms during the
preparation of the hemoglobin solutions is reduced to ferrohemoglobin by
this compound, and no oxyhemoglobin can form in the presence of an
excess of sodium dithionite because of the high rate of reaction of oxygen
with this reducing agent. Both ferrihemoglobin and oxyhemoglobin are
considerably more soluble than ferrohemoglobin, and their temporary
presence might result in supersaturation. The amount of dithionite,
while sufficient to maintain the hemoglobin20 in the reduced, unoxygenated
state, was small in relation to the total phosphate concentration of the
buffer, so that its decomposition did not alter significantly the pH or the
total ionic strength of the solutions. It was found that the equilibrium
concentration of hemoglobin was attained within the time required to
precipitate and separate by centrifugation the excess hemoglobin as amor-
phous solid. In the case of normal hemoglobin, presumably a one-com-
ponent protein, the solubility of the amorphous phase was independent of
the amount of the solid present. The solubility of sickle cell trait hemo-
globin increased with the amount of the solid phase present, approaching
a limiting value in the presence of a large excess of the two-component hemo-
globin. Repeated centrifugation and resuspension of an amorphous precipi-
tate of normal hemoglobin resulted in the formation of crystalline ferrohemo-
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globin, which has a lower solubility than the amorphous form. The fore-
going results, plus the reproducibility of the results as indicated by figure
1, indicate that amorphous hemoglobin possesses a metastable equilibrium
solubility which is characteristic of the type of hemoglobin and of the con-
centration of the solvent buffer, and which is greater than that of the crys-
talline form. These results are in accord with those obtained by other
workers'6'21 on the crystalline and amorphous hemoglobins of several species.
The actual solubility in moles per liter22 of sickle cell trait hemoglobin
falls much closer to that of sickle cell anemia hemoglobin than to that of
normal hemoglobin although the percentage of sickle cell hemoglobin in
sickle cell trait is always smaller than that of normal hemoglobin.'0 This
indicates that, unlike the system treated by Northrop and Kunitz,23 the
amorphous solid solution of normal and sickle cell hemoglobin does not
show a Raoult's Law type of behavior in its solubility but has a solubility
much lower than that predicted from Raoult's Law. This finding pre-
cludes the determination of the composition of sickle cell trait hemoglobin
in its two components from solubility data alone. The deviation of the
sickle cell trait solubility data from a straight line in the high solubility
region is undoubtedly due to the fact that in the experiments in this region
the excess of hemoglobin present was small, and the composition of the
solid phase was significantly altered by the solution of a large fraction of
the added hemoglobin.
The observations that the solubilities of the two-component hemo-
globins of M. H. and G. H. are nearly the same as those of normal hemo-
globin and five to seven times as great as that of sickle cell- trait hemoglobin,
which has the same electrophoretic pattern, provide conclusive proof that
the abnormal component in the hemoglobins of these individuals is not
sickle cell hemoglobin. These results also suggest that, barring large
interaction effects, the solubility of this abnormal hemoglobin is of the same
order of magnitude as that of normal hemoglobin, which is about 14 times
as soluble as sickle cell hemoglobin in the amorphous state. Thus the
presence of a hitherto unreported hemoglobin component in the erythro-
cytes of M. H., the mother, G. H., and probably H. H. D. has been estab-
lished without consideration of the data presented by the studies on R. H.
and B. H. Probably the major electrophoretic component of the hemo-
globins of the latter individuals contains two abnormal hemoglobins
migrating with the same mobility. The presence of sickle cell hemoglobin
is indicated by (1) the positive sickling test and relatively low solubility
of their hemoglobins, (2) the. identity of the electrophoretic mobility of
the major component of their hemoglobins with that of sickle cell hemo-
globin and (3) the presence of sickle cell trait in their father. The presence
of the other hemoglobin, which henceforth will be called hemoglobin d,
is indicated by (1) the greater solubility of their hemoglobins in com-
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parison with sickle cell anemia hemoglobins having the same or very similar
electrophoretic patterns and mobilities and (2) the presence of this hemo-
globin in their mother and two siblings.
The explanation for the greater solubility of B. H.'s hemoglobin as
compared to R. H.'s may lie in the electrophoretic result that B. H.'s
hemoglobin has about 12% of a component having the mobility of normal
hemoglobin while R. H.'s hemoglobin has only about 6% of this component.
Another possible explanation is that R. H.'s hemoglobin may contain a
greater percentage of sickle cell hemoglobin than B. H.'s. The difference
in the slopes of the solubility curves of the hemoglobins from these two
individuals is in large part due to low values of solubilities of B. H.'s
hemoglobins at ionic strengths 4.7 and 5.0. Hemoglobin was present in
but small excess in these experiments, and the same effect which diminishes
the solubility of sickle cell trait hemoglobin when it is present in small
excess accounts for these results.
Abnormally shaped erythrocytes are more susceptible to intravascular
destruction than are nornal erythrocytes.24, 25 The great difference in
the pathological cdnsequences of sickle cell anemia and sickle cell trait
as well as the gradations in the severity of different cases of sickle cell
anemia can be related to the fraction of the total hemoglobin which is
present as sickle cell hemoglobin." 4, 10 When this fraction is sufficiently
high as to cause sickling at the partial pressure of oxygen in venous blood,
intravascular hemolysis and anemia result. The question may well arise
as to why the combination of sickle cell hemoglobin and hemoglobin d
causes anemia when hemoglobin d appears to be just as soluble as normal
hemoglobin. One possible answer is that the percentage of hemoglobin
d in the erythrocytes is low; another is suggested by the solubility data
on sickle cell trait hemoglobin. As was previously pointed out, these
data indicate the presence of an interaction between normal and sickle cell
hemoglobin which stabilizes the solid phase and diminishes the solubility
of a mixture of these two hemoglobins to less than a theoretically predicted
value. A similar interaction may stabilize the aggregates in sickling
erythrocytes; and if the stabilizing interaction between sickle cell hemo-
globin and hemoglobin d were greater than that between sickle cell hemo-
globin and normal hemoglobin, the presence of a high percentage of sickle
cell hemoglobin need not be postulated in order to explain an increased
susceptibility to sickling. The same possibilities may be considered with
regard to the origin of the anemia which accompanies the presence of the
combination of sickle cell hemoglobin and hemoglobin c in an individual;
in this case it has been determined electrophoretically that the erythrocytes
in the known cases contain about 50% of hemoglobin c.5
The genetic picture in this family appears to be analogous to the pictures
presented by the families in which the sickle cell-hemoglobin c combina-
tion" and the sickle cell-thalassemia combination3 4 are present. In each
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of these cases an erythrocyte abnormality has been detected in the non-
sickling parent of an individual having a syndrome resembling sickle
cell anemia. In discussing one of these cases Neel3 has presented three
possible genetic mechanisms for the transmission of the sickle cell and
thalassemia characters. The decision as to the actual mechanism involved
must await the accumulation of more data involving similar families and
the examination of the descendants of individuals possessing the same
hemoglobin constitution as R. H. and B. H. If the marriage of R. H. or
B. H. to an individual having only normal hemoglobin results in a child
having only normal hemoglobin, non-allelism of the genes responsible for
the formation of sickle cell hemoglobin and hemoglobin d would be in-
dicated. Although neither hemoglobin c nor hemoglobin d has been found
free of other hemoglobins, this work does not provide any evidence that
such states would necessarily be lethal.
The existence of other genetic forms of human hemoglobin is quite
probable, but the problem of detecting and characterizing forms which do
not produce hematologic and clinical disorders may prove difficult. Sickle
cells have been observed in deer,26 and an abnormal form of adult sheep
hemoglobin has been detected in a lamb.'2 A systematic search would
probably disclose the existence of chemically and genetically different
forms of hemoglobin within other species. The search need not be con-
fined to hemoglobins; the electrophoretically distinct components of
crystaUine serum albumin27 and ovalbumin28 may be of genetic significance.
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SPONTANEOUS AND ULTRA-VIOLET-INDUCED MUTATIONS
TO PHAGE RESISTANCE IN ESCHERICHIA COLI*
By VERNON BRYSON AND HARRIET DAVIDSON
BIOLOGICAL LABORATORY, COLD SPRING HARBOR, NEW YORK
Communicated by M. Demerec, October 27, 1951
One of the fundamental problems of genetics is the nature of differences
between spontaneous and induced mutation. In higher organisms, muta-
tions induced by ionizing radiations are known to include a relatively large
number of chromosomal aberrations. Yet there is no doubt that spon-
taneously occurring chromosomal abnormalities have been important
phylogenetically, and may themselves be the secondary consequences of
spontaneous genetic changes.
Bonnier and Luning1 observe that the regression line expressing a linear
relationship between intermediate doses of x-ray and mutation frequency
in Drosophila fails to intercept the point derived from untreated and
slightly irradiated controls. Similar findings have been obtained by
Spencer and Stern2 with departures from linearity established as significant
by Boag3 using a probit diagram. It is at least possible that the deficit
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